InvestorBrandNetwork (IBN) logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

InvestorNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Builds Commercial Case for GelrinC in Multi-Billion Knee Cartilage Repair Market

August 14, 2026 — Regentis Biomaterials (NYSE American: RGNT) was featured in a recent article highlighting the potential of its GelrinC cell-free hydrogel implant to address longstanding challenges in focal knee injuries through an off-the-shelf treatment designed to simplify surgical workflows, support faster recovery and promote durable tissue regeneration. The company recently received European regulatory approval for a next-generation, solvent-free manufacturing process that increases production yield by approximately 400%, supporting greater scalability and lower production costs.

MissionIRNewsBreaks – Wrap Technologies, Inc. (NASDAQ: WRAP) Selected to Support Florida Teacher Safety Training Program

August 14, 2026 — Wrap Technologies (NASDAQ: WRAP) has been selected by WOFT Charities (“WOFT”) to provide training support for the WOFT Teacher Safety Training Program, which received a $475,000 appropriation in Florida’s fiscal year 2026-27 state budget. WRAP will support training focused on situational awareness, threat recognition, early intervention, de-escalation and avoiding physical confrontation when possible.

InvestorNewsBreaks – American Fusion Inc. (OTC: AMFN) Highlights Growing Power Demand, Advances Texatron(TM) Commercialization Strategy

August 14, 2026 — American Fusion (OTC: AMFN) provided an industry and market update highlighting accelerating fusion investment and growing electricity demand from artificial intelligence data centers, hospitals and other mission-critical infrastructure. The company is developing its Texatron(TM) Fusion Engine(TM) as a potential scalable source of distributed electricity, with a long-term Power-as-a-Service model under which American Fusion would own, operate and maintain generating assets and sell electricity directly to customers behind the meter.

MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Advances Heart Attack Detection Program, Extends Cash Runway Into 2027

August 14, 2026 — HeartBeam (NASDAQ: BEAT) reported second-quarter 2026 financial and operational results, highlighting progress across its heart attack detection program, 12-lead ECG extended wear patch and initial commercial launch. The company completed enrollment of 134 patients in its ALIGN-ACS pilot study ahead of schedule, with full results expected to be presented at TCT 2026, and surpassed 50% enrollment in its 500-patient HEADSTART-ACS pilot study.

MissionIRNewsBreaks – AZIO AI Holdings, Inc. (NASDAQ: AZIO) Featured in NetworkNewsAudio on AI Power and Infrastructure Constraints

August 14, 2026 — AZIO AI Holdings (NASDAQ: AZIO) is featured in a NetworkNewsAudio Audio Press Release examining how power availability, specialized data-center capacity and high-speed connectivity are emerging as critical constraints on AI expansion. The editorial highlights AZIO AI’s planned 500-megawatt AI data-center campus in Texas, which is designed to address these infrastructure challenges by securing power and connectivity in parallel.

InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Appoints Intellectual Property Veteran Dean Becker as Chief Licensing Officer

August 14, 2026 — Datavault AI (NASDAQ: DVLT) has appointed Dean Becker as chief licensing officer, giving him executive responsibility for the licensing, valuation and monetization of the company’s global intellectual property portfolio. Becker brings more than 30 years of experience and has completed billions of dollars in intellectual property-based transactions, including creating the Ocean Tomo patent auction business and later serving for a decade as CEO of multiple ICAP intellectual property businesses.

NetworkNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Advances AI-Driven Oncology Pipeline, Establishes Open Medicine AI

August 14, 2026 — Lantern Pharma (NASDAQ: LTRN), reported second-quarter 2026 operational and financial results, highlighting progress across its AI-driven oncology pipeline and the establishment of Open Medicine AI (“OMAI”) as a separate company. Emerging data from the Phase 2 HARMONIC(TM) trial showed LP-300’s progression-free survival benefit deepening with treatment duration in patients with EGFR exon 21 L858R mutations, while the FDA reviewed key protocol amendments without objection.